Correction: An ROS-sensitive tegafur-PpIX-heterodimer-loaded in situ injectable thermosensitive hydrogel for photodynamic therapy combined with chemotherapy to enhance the tegafur-based treatment of breast cancer

Key Points

• This research aims to enhance the efficacy of tegafur-based treatment for breast cancer.
• Developed a thermosensitive hydrogel for injectable use.
• Combined photodynamic therapy with chemotherapy in a unique delivery system.
• Tested the hydrogel's ROS-sensitive properties.
• Improved treatment outcomes for breast cancer cells with the combined approach.
• Demonstrated effective drug release through the hydrogel.
• Showed increased cytotoxicity in cancer cells compared to standard treatment.